HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Simón Selected Research

Dirofilariasis

7/2019A possible relationship between Thromboxane B2 and Leukotriene B4 and the encapsulation of Dirofilaria repens worms in human subcutaneous dirofilariasis.
11/2014Cardiopulmonary and inflammatory biomarkers in the assessment of the severity of canine dirofilariosis.
10/2013Utility of cardiac biomarkers during adulticide treatment of heartworm disease (Dirofilaria immitis) in dogs.
7/2013Variation of D-dimer values as assessment of pulmonary thromboembolism during adulticide treatment of heartworm disease in dogs.
1/2013D-dimer deposits in lungs and kidneys suggest its use as a marker in the clinical workup of dogs with heartworm (Dirofilaria immitis) disease.
10/2012Myocardial damage in dogs affected by heartworm disease (Dirofilaria immitis): immunohistochemical study of cardiac myoglobin and troponin I in naturally infected dogs.
3/2011Dirofilaria immitis infection in dogs: cardiopulmonary biomarker levels.
10/2005What is happening outside North America regarding human dirofilariasis?
10/2005Is Wolbachia complicating the pathological effects of Dirofilaria immitis infections?
1/2003Immunoglobulin G antibodies against the endosymbionts of filarial nematodes (Wolbachia) in patients with pulmonary dirofilariasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Simón Research Topics

Disease

13Infections
01/2019 - 02/2002
10Dirofilariasis
07/2019 - 01/2003
3Inflammation (Inflammations)
01/2019 - 12/2008
3Pulmonary Embolism
07/2013 - 03/2011
1Fascioliasis
01/2019
1Nervous System Diseases (Neurological Disorders)
01/2019
1Thromboembolism
11/2014
1Disseminated Intravascular Coagulation
11/2014
1Pathologic Processes
10/2013
1Myositis (Idiopathic Inflammatory Myopathies)
10/2013
1Thrombocytopenia (Thrombopenia)
07/2013
1Thrombosis (Thrombus)
01/2013
1Necrosis
10/2012
1Bites and Stings (Sting)
10/2010
1Hematoma
08/2005

Drug/Important Bio-Agent (IBA)

5AntigensIBA
12/2008 - 02/2003
4AntibodiesIBA
01/2019 - 02/2002
4fibrin fragment D (D-dimer)IBA
11/2014 - 03/2011
4MyoglobinIBA
11/2014 - 03/2011
4Immunoglobulin G (IgG)IBA
07/2005 - 01/2003
3EicosanoidsIBA
07/2019 - 07/2007
3Biomarkers (Surrogate Marker)IBA
11/2014 - 03/2011
3Troponin IIBA
11/2014 - 03/2011
3Membrane Proteins (Integral Membrane Proteins)IBA
10/2005 - 01/2003
2ImmunosorbentsIBA
07/2019 - 02/2002
2Leukotriene B4IBA
07/2019 - 07/2007
2Biological ProductsIBA
10/2013 - 03/2011
2Proteins (Proteins, Gene)FDA Link
10/2012 - 02/2003
2EnzymesIBA
12/2008 - 02/2002
2Ivermectin (Mectizan)FDA Link
07/2007 - 02/2002
1Thromboxane B2IBA
07/2019
1BradykininIBA
01/2019
1Carrier Proteins (Binding Protein)IBA
01/2019
1PlasminogenIBA
01/2019
1Antifibrinolytic Agents (Antifibrinolytics)IBA
01/2019
1pro-brain natriuretic peptide (1-76)IBA
11/2014
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2014
1C-Reactive ProteinIBA
11/2014
1melarsomineIBA
10/2013
1Fibrin Fibrinogen Degradation ProductsIBA
01/2013
1Troponin T (Troponin T1)IBA
03/2011
1Prostaglandins EIBA
12/2008
1Dinoprostone (PGE2)FDA Link
07/2007
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2007
1Interleukin-4 (Interleukin 4)IBA
01/2007
1Messenger RNA (mRNA)IBA
01/2007
1Interleukin-10 (Interleukin 10)IBA
01/2007
1Local AnestheticsIBA
08/2005
11,3-di(4-imidazolinophenoxyl)propaneIBA
11/2004
1CytokinesIBA
02/2003

Therapy/Procedure

1Intramuscular Injections
10/2013
1Therapeutics
07/2013
1Drug Therapy (Chemotherapy)
10/2010
1Aftercare (After-Treatment)
07/2007
1Conduction Anesthesia (Regional Anesthesia)
08/2005
1Anesthesia
08/2005